<DOC>
	<DOCNO>NCT00037570</DOCNO>
	<brief_summary>This multicenter , randomize , double-blind , parallel-group , dose-ranging , comparator-controlled study effect pantoprazole intragastric pH successful endoscopic hemostasis hospitalize patient . Patients receive either intravenous pantoprazole ( one two regimen ) ranitidine ( comparator ) within 2 hour successful hemostasis administration continue 72 hour hemostasis .</brief_summary>
	<brief_title>Study Evaluating Pantoprazole Peptic Ulcer Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Patients must men nonpregnant woman least 18 year age Patients present gastric duodenal ulcer ( major dimension ulcer must ≥ 5 mm ≤ 20 mm ) endoscopic appearance spurting , ooze , nonbleeding visible vessel ( NBVV ) Patients present adherent protruding clot eligible , removal clot irrigation , underlie lesion classify spurting , ooze NBVV . Patients actively bleed ulcer NBVV within hiatal hernia eligible ulcer locate Zline ) Patients ulcer appearance clean base ( nonoozing , nonspurting ) flat pigment spot ; adherent clot remove irrigation Patients present active bleeding and/or NBVV 2 separate site Patients severe concomitant disease , eg , endstage liver renal disease , unstable cardiovascular , pulmonary , renal , hepatic , gastrointestinal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Peptic</keyword>
	<keyword>Ulcer</keyword>
	<keyword>Hemorrhage</keyword>
</DOC>